Northern Trust’s Acumen Pharmaceuticals ABOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $75.6K | Sell |
65,162
-224,674
| -78% | -$261K | ﹤0.01% | 4168 |
|
|
2025
Q1 | $319K | Sell |
289,836
-17,779
| -6% | -$19.6K | ﹤0.01% | 3770 |
|
|
2024
Q4 | $529K | Sell |
307,615
-1,235
| -0.4% | -$2.12K | ﹤0.01% | 3634 |
|
|
2024
Q3 | $766K | Buy |
308,850
+238,762
| +341% | +$592K | ﹤0.01% | 3442 |
|
|
2024
Q2 | $170K | Buy |
70,088
+13,315
| +23% | +$32.2K | ﹤0.01% | 3913 |
|
|
2024
Q1 | $230K | Buy |
56,773
+95
| +0.2% | +$385 | ﹤0.01% | 3846 |
|
|
2023
Q4 | $218K | Buy |
56,678
+488
| +0.9% | +$1.87K | ﹤0.01% | 3874 |
|
|
2023
Q3 | $233K | Buy |
56,190
+24,096
| +75% | +$100K | ﹤0.01% | 3746 |
|
|
2023
Q2 | $154K | Sell |
32,094
-64
| -0.2% | -$308 | ﹤0.01% | 3914 |
|
|
2023
Q1 | $131K | Sell |
32,158
-2,226
| -6% | -$9.04K | ﹤0.01% | 4009 |
|
|
2022
Q4 | $186K | Buy |
34,384
+8,642
| +34% | +$46.7K | ﹤0.01% | 3900 |
|
|
2022
Q3 | $259K | Buy |
25,742
+4,196
| +19% | +$42.2K | ﹤0.01% | 3748 |
|
|
2022
Q2 | $101K | Sell |
21,546
-194,622
| -90% | -$912K | ﹤0.01% | 4162 |
|
|
2022
Q1 | $845K | Buy |
216,168
+121,184
| +128% | +$474K | ﹤0.01% | 3506 |
|
|
2021
Q4 | $642K | Buy |
94,984
+7,583
| +9% | +$51.3K | ﹤0.01% | 3720 |
|
|
2021
Q3 | $1.3M | Buy |
+87,401
| New | +$1.3M | ﹤0.01% | 3461 |
|